US Stock Market Move | Blue Origin rocket launch mission thwarted, AST SpaceMobile (ASTS.US) opening plunges over 10%
On Monday, AST SpaceMobile (ASTS.US) opened with a sharp drop of over 10%, trading at $76.79.
On Monday, AST SpaceMobile (ASTS.US) opened with a drop of over 10%, at $76.79. On the news front, Jeff Bezos' Blue Origin's "New Glenn" rocket failed to deliver the satellites manufactured by the company into the intended orbit. Blue Origin carried out the third mission of the "New Glenn" rocket on Sunday and successfully reused the booster for the first time, but the payload did not reach the planned orbit. In a social media post, Blue Origin stated that although the satellite had separated from the second stage of the "New Glenn" rocket, it entered an "anomalous orbit."
In response to the launch, AST SpaceMobile said, "Due to the low orbit height, the satellite cannot maintain its operation using onboard thrusters, and will undergo orbital correction." It is expected that the cost of the satellite will be recovered through the company's insurance policy. It is worth noting that this setback may complicate Blue Origin's efforts to position "New Glenn" as a strong competitor to SpaceX's "Falcon 9". The heavy-lift rocket has faced delays for years and its launch schedule is slower than expected.
Related Articles
.png)
US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%

The resurgence of tariffs clouds the prospects of the industrial sector, and the "top students" of the US stock market face a major performance test.

US Stock Market Move | The drug trial for alopecia achieved expected results, and Nektar Therapeutics (NKTR.US) soared over 24%.
US Stock Market Move | Most Star Tech Stocks fall Intel Corporation (INTC.US) drop over 3%
.png)
The resurgence of tariffs clouds the prospects of the industrial sector, and the "top students" of the US stock market face a major performance test.

US Stock Market Move | The drug trial for alopecia achieved expected results, and Nektar Therapeutics (NKTR.US) soared over 24%.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


